Cytokinetics, Incorporated

CYTK · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$95$113$66$113
Short-Term Investments$981$502$717$359
Receivables$17$1$0$52
Inventory$0$0$0$0
Other Curr. Assets$15$12$12$12
Total Curr. Assets$1,108$628$795$536
Property Plant & Equip (Net)$141$148$163$146
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$145$41$47$152
Tax Assets$0$0$0$0
Other NC Assets$8$8$10$7
Total NC Assets$294$196$220$306
Other Assets$0$0$0$0
Total Assets$1,402$824$1,015$841
Liabilities
Payables$20$22$26$21
Short-Term Debt$30$28$14$15
Tax Payable$0$0$0$0
Deferred Revenue$52$0$0$0
Other Curr. Liab.$76$53$45$36
Total Curr. Liab.$180$103$85$72
LT Debt$758$728$737$255
Deferred Rev, NC$0$0$0$87
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$599$380$302$184
Total NC Liab.$1,357$1,108$1,038$526
Other Liabilities$0$0$0$0
Cap. Leases$132$138$140$127
Total Liabilities$1,537$1,211$1,123$597
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$2,702-$2,112-$1,586-$1,208
AOCI$2-$0-$4-$1
Other Equity$2,564$1,726$1,482$1,452
Total Equity-$135-$386-$108$244
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,402$824$1,015$841
Net Debt$694$643$685$157
Cytokinetics, Incorporated (CYTK) Financial Statements & Key Stats | AlphaPilot